Related Experiment Videos
[Efficacy of tumor necrosis factor-alpha blockade for severe sciatica?].
Stéphane Genevay1, Pierre-André Guerne, Cem Gabay
1Service de rhumatologie HUG, Hôpital Beau-Séjour, Genève. stephane.genevay@hcuge.ch
Revue Medicale De La Suisse Romande
|November 24, 2004
Summary
Sciatica may be caused by local inflammation, not just nerve compression. Anti-inflammatory treatments targeting tumor necrosis factor-alpha (TNF-α) show promise for sciatica relief.
Area of Science:
- Neurology
- Inflammation research
- Pain management
Context:
- Sciatica is commonly attributed to nerve compression, but emerging evidence suggests local inflammation plays a significant role.
- Inflammatory mediators have been identified in human herniated discs, supporting the inflammation hypothesis.
- Animal models demonstrate that nerve root compression alone does not cause sciatica without inflammation.
Purpose:
- To review the evidence supporting a local inflammation hypothesis for sciatica.
- To highlight the role of proinflammatory cytokines, particularly tumor necrosis factor-alpha (TNF-α), in sciatica pathogenesis.
- To discuss the potential of TNF-α modulators as a therapeutic strategy for sciatica.
Summary:
- Accumulating evidence over ten years favors a local inflammation model for sciatica over simple nerve compression.
- Proinflammatory cytokines, especially TNF-α, are crucial in sciatica, as shown in animal models where TNF-α modulators proved effective.
- Two pilot human studies corroborate these findings, with a large multicenter trial planned.
Impact:
- This research shifts the understanding of sciatica from a purely mechanical issue to an inflammatory condition.
- It opens new avenues for sciatica treatment focusing on anti-inflammatory therapies, particularly TNF-α inhibitors.
- The findings pave the way for more effective and targeted treatments for sciatica patients.